Document Detail


A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
MedLine Citation:
PMID:  21683049     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
ABSTRACT. Objective: The objectives of this study were to (a) identify the patterns of disulfiram (Antabuse) and tablet naltrexone (Revia) adoption over a 48-month period in a nationally representative sample of privately funded programs that deliver substance use disorder treatment; (b) examine predictors of sustainability, later adoption, discontinuation, and nonadoption of disulfiram and tablet naltrexone; and (c) measure reasons for medication discontinuation. Method: Two waves of data were collected via face-to-face structured interviews with 223 program administrators. Results: These data demonstrated that adoption of medications for alcohol use disorders (AUDs) was a dynamic process. Although nonadoption was the most common pattern, approximately 20% of programs sustained use of the AUD medications and 30% experienced organizational change in adoption over the study period. Bivariate multinomial logistic regression models revealed that organizational characteristics were associated with sustainability including location in a hospital setting, program size, accreditation, revenues from private insurance, referrals from the criminal justice system, number of medical staff, and use of selective serotonin reuptake inhibitors at baseline. Two patterns of discontinuation were found: Programs either discontinued use of all substance use disorder medications or replaced disulfiram/tablet naltrexone with a newer AUD medication. Conclusions: These findings suggest that adoption of AUD medications may be positively affected by pressure from accreditation bodies, partnering with primary care physicians, medication-specific training for medical staff, greater availability of resources to cover the costs associated with prescribing AUD medications, and amending criminal justice contracts to include support for AUD medication use. (J. Stud. Alcohol Drugs, 72, 669-677, 2011).
Authors:
Amanda J Abraham; Hannah K Knudsen; Paul M Roman
Related Documents :
8412879 - Medical student abuse: perceptions and experience.
6095459 - Multiple therapeutic use in urban nepal.
7728719 - Bicycle helmet use and compliance: a northeastern ontario roadside survey.
8164899 - The survival story of a child with ondine's curse in northland.
17786649 - Complexities in reproductive choice: medical professionals' attitudes to and experience...
3942449 - Physicians' assessment of cognitive capacity. failure to meet the needs of the elderly.
7310619 - Clinical prediction of medical rehospitalization: psychological assessment with the bat...
21371989 - Subdividing the digital divide: differences in internet access and use among rural resi...
1004299 - Assessment of insight change in medical student doing psychiatry.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of studies on alcohol and drugs     Volume:  72     ISSN:  1938-4114     ISO Abbreviation:  J Stud Alcohol Drugs     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-06-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101295847     Medline TA:  J Stud Alcohol Drugs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  669-77     Citation Subset:  IM    
Affiliation:
Institute for Behavioral Research, 112 Barrow Hall, University of Georgia, Athens, Georgia 30602-2401.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Six-month changes in spirituality and religiousness in alcoholics predict drinking outcomes at nine ...
Next Document:  Alcohol use and problem severity: associations with dual systems of self-control.